Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Short SellingSee which listed companies have disclosed short interest
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Børsurougen | Sundhed & Vækst og M&A 8.9.2026

Analyst Comment09.09.2026, 06.35
Inderes

Summary

  • Arrangementet "Børsurougen" den 8.9.2026 fokuserer på investeringer inden for sundhed og vækst samt M&A, med præsentationer fra ledere i virksomheder som Aiforia, Terveystalo, Orion, Relais og Aspo.
  • Programmet inkluderer introduktioner og dybdegående analyser af investeringsmuligheder fra ledende figurer som Jukka Tapaninen, Juuso Pajunen og Rolf Jansson.
  • Alle præsentationer kan ses live på inderesTV og er tilgængelige som optagelser, hvilket giver investorer mulighed for at få indsigt i forskellige sektorer gennem ugen.

Dette indhold er genereret af AI. Du kan give feedback om det på Inderes forum.

Automatisk oversættelse: Oprindeligt udgivet på finsk 9.9.2026, 04.35 GMT. Giv feedback her.

PROGRAM FOR TIRSDAG DEN 8.9.2026:

Børsinvestorens uge | Sundhedssektoren

  • Velkommen! Introduktion til dagens tema: Savanna Saarikko, Jyri Tuominen & Antti Siltanen (link)
  • Aiforia som investering: Jukka Tapaninen, adm. direktør, Aifora Technologies (link)
  • Terveystalo som investering: Juuso Pajunen, CFO, Terveystalo (link)
  • Orion Pharma som investering: Tuukka Hirvonen, Head of Investor Relations, Orion Pharma (link)

Børsinvestorens uge | Vækst og Virksomhedsopkøb

  • Velkommen! Introduktion til dagens tema: Antti Mustonen, Savanna Saarikko & Kasper Mellas (link)
  • Relais som investering: Christian Gebauer, adm. direktør, Relais (link)
  • Aspo som investering: Rolf Jansson, adm. direktør, Aspo (link)

...Alle ugens præsentationer kan ses live på inderesTV og senere som optagelse:

MANDAG DEN 7.9.2026Finans

TIRSDAG DEN 8.9.2026Sundhedssektoren & Vækst og Virksomhedsopkøb

ONSDAG DEN 9.9.2026Medie & Teknologi

TORSDAG DEN 10.9.2026Forbrugere og Handel

FREDAG DEN 11.9.2026Industri & Ingeniørvirksomheder

MANDAG DEN 14.9.2026Ekstradag

Stay up to date
Aiforia Technologies
Terveystalo
Orion
Relais Group
Aspo

Forum discussions

Comments on the latest move LinkedIn #digitalpathology #ai #lifesciences #diagnostics | Paul Atkinson First Roche and PathAI. Now Agilent Technologies...
yesterday
by Vino Pino
16
thepathologist.com The Pathologist | Pathology Visions 2026 – Digital Pathology Conference Aiforia will also be featured there in a few days...
yesterday
by Salvelinus
11
Here are Antti’s comments regarding the acquisition of Aiforia’s partner by Agilent, a US-based laboratory and diagnostics company. The cash...
yesterday
by Sijoittaja-alokas
16
Here are Antti’s comments from when Aiforia signed the deal with PathAI. Aiforia announced on Thursday that it had entered into a commercial...
10/9/2026, 4:45 AM
by Sijoittaja-alokas
10
Kotimainen palkinto Aiforialle: Messukeskuksessa juhlittiin suomalaisia maailmanluokan tekoälyratkaisuja – Opetushallitus ja Aiforia nappasivat...
10/8/2026, 6:27 PM
by NukkeNukuttaja
16
Aiforia aloittaa yhteistyön PathAI:n kanssa laajentaakseen tekoälypohjaisen diagnostiikan saatavuutta Aiforia aloittaa yhteistyön PathAI:n kanssa...
10/8/2026, 6:09 AM
by Kulkuri
30
In my opinion, the CEO holds their own quite well in this panel. Sure, this industry is still pretty much in its infancy, but before you know...
10/1/2026, 11:52 AM
by Salvelinus
12